Chinese Scientists Develop Innovative Stem Cell Therapy for Parkinson's Disease

Chinese medical experts have developed an ultra-efficient stem cell therapy for Parkinson's disease, a condition for which there is currently no known cure. This innovative approach, led by neurology specialist Shi Jiong at the First Affiliated Hospital of the University of Science and Technology of China in Hefei, has demonstrated a remarkable conversion rate of over 80 percent in differentiating stem cells into functional cells.

In comparison, internationally leading teams have reported conversion rates of around 50 percent. Since mid-2023, Shi's team has been conducting a Phase I clinical trial involving stem cell transplant treatment.

Six patients have participated in the trial, showing rapid improvement in their symptoms, including a significant and sustained increase in dopamine signaling within the brain. One participant, a 37-year-old woman surnamed Li, began losing motor control at age 22 but has largely achieved a functional cure and returned to normal life just three months after undergoing the treatment.

This breakthrough offers new hope for millions affected by Parkinson's disease.